Corporate & Investor Presentation

Our partnerships will address sleep health as a public health crisis Sleep research joint venture with Verily Develop software solutions to help identify, diagnose, treat, and manage those with OSA • To study the health and financial impacts of untreated sleep apnea - Prove the ROI for treating OSA Identify, engage, enroll Expand the funnel & verily ResMed 100 600 With Verily, we can unlock richer, more holistic insights about sleep apnea and the value of treating it 12 2021 ResMed | Corporate & Investor Presentation - updated 28JAN21 ResMed

View entire presentation